Imagion Biosystems Limited
ASX:IBX.AX
0.05 (AUD) • At close November 4, 2024
Overzicht | Financiële gegevens
Bedrijfsnaam | Imagion Biosystems Limited |
Symbool | IBX.AX |
Munteenheid | AUD |
Prijs | 0.053 |
Beurswaarde | 2,281,051 |
Dividendpercentage | 0% |
52-weken bereik | 0.022 - 0.48 |
Industrie | Diagnostics & Research |
Sector | Healthcare |
CEO | Dr. Isaac J. Bright M.D. |
Website | https://imagionbiosystems.com |
An error occurred while fetching data.
Over Imagion Biosystems Limited
Imagion Biosystems Limited provides medical imaging technologies based on superparamagnetic relaxometry for cancer and disease detection, and monitoring therapy. It has activities in nanotechnology; biotechnology; cancer diagnostics; and superparamagnetic relaxometry. The company develops MagSense, which is in Phase I clinical trials for the treatment of HER2 breast cancers; and PrecisionMRX,
Vergelijkbare Aandelen
Financiële Gegevens
Cijfers zijn in miljoenen (AUD)
Cijfers zijn in miljoenen (AUD)